Conference Details

2nd International Conference On Cell And Genetherapy

  • Health and Medicine
  • Education
  • Life Science
  • Conference
  • Apr 15, 2019 - Apr 16, 2019
  • Milan Italy
  • Milan, Italy
  • Rating:
Paper Submission Date
03-25-19
Registration Date
01-02-19
Acceptance Notification Date
03-25-19

Description

Join with Featured Speakers and Experts from Europe, USA, Middle East and Asia Pacific at 2nd International Conference on Cell and Genetherapy on April 15-16, 2019 at Milan, Italy. For more details visit : http://celltherapycongress.alliedacademies.com/

 


List of Main Topics

  • Cell Therapy
  • Gene Therapy
  • Stem Cell Therapies
  • Cell Culture and Bioprocessing
  • Tissue Science & Regenerative Medicine
  • Clinical Trials on Cell & Gene Therapy
  • Nano Therapy
  • Advanced Gene Therapeutics
  • Gene and Cell Therapy for Rare & Common Diseases
  • Cell Science and Stem Cell Research
  • Molecular Basis of Epigenetics
  • Genetics and Stem Cell Biology
  • Regulatory and Safety Aspects of Cell and Gene Therapy
  • Markets & Future Prospects for Cell & Gene Therapy
  • Cell Biology
  • Gene editing and CRISPR based technologies
  • Genetics & Genomic Medicine
  • Bioengineering Therapeutics
  • Immunogenetics & Transplantation
  • Biomarkers

Speakers

Theresa A Deisher

Theresa A. Deisher obtained...

Read more

Theresa A. Deisher obtained her Ph.D. in Molecular and Cellular Physiology from Stanford University School of Medicine. An expert in adult stem cell research, she is the first person to discover adult pluripotent stem cells. She is an inventor of over 35 issued US/Japan patents, whose discoveries have led to clinical trials of fibroblast growth factor 18 for osteoarthritis and cartilage repair, and for Factor XIII for surgical bleeding. Prior to founding AVM Biotechnology, she worked at leading biotechnology companies including Genentech, Repligen, ZymoGenetics, Immunex and Amgen as their principal scientist and R&D Vice President. She has had extensive scientific and management experience in the commercial biotechnology field, including: • Genentech 1988-1990 • Repligen 1993-1995 – Hematopoietic Stem Cell Chemoattractants • ZymoGenetics 1995-2000 – Adult Cardiac Stem Cell; Mesodermal – Derived Stem Cell; VSEL Very Small Embryonic-Like Stem • Immunex/Amgen 2000-2006 – Derivation of Embryonic-Like Stem Cells from Human Cord Blood. She is a frequent lecturer on stem cell issues and an active member of ASH (The American Society of Hematology) and ASCO (ASCO: American Society of Clinical Oncology)   

Read Less

Submission Instructions

Cell and Genetherapy will be organized around the theme Novel Innovations in Cell and Genetherapy

Cell and Genetherapy 2019 is consists of 20tracks and 59 sessions designed to offer comprehensive sessions that address current issues in cell-and-genetherapy-2019


Submission Dates

Abstract Date
03-25-19

Registration Fee and Instructions

For Registration Visit:http://celltherapycongress.alliedacademies.com/registration

 


Accommodations

Package-A (Which includes Registration+2 Nights Accommodation) = 899$

Package-B (Which includes Registration+3 Nights Accommodation) = 1099$


Exhibit Information

  • Company acknowledgement on all official conference support signs, program and on all marketing collateral including enhanced logo on the conference holding slide
  • Special recognition on the conference website
  • Complimentary table top exhibition
  • One set of promotional materials included in registration material
  • Waiver on Sponsorship for any of our next year conference
  • Booth Cost $1500